Literature DB >> 17584037

Current advances and future challenges in Adenoviral vector biology and targeting.

Samuel K Campos1, Michael A Barry.   

Abstract

Gene delivery vectors based on Adenoviral (Ad) vectors have enormous potential for the treatment of both hereditary and acquired disease. Detailed structural analysis of the Ad virion, combined with functional studies has broadened our knowledge of the structure/function relationships between Ad vectors and host cells/tissues and substantial achievement has been made towards a thorough understanding of the biology of Ad vectors. The widespread use of Ad vectors for clinical gene therapy is compromised by their inherent immunogenicity. The generation of safer and more effective Ad vectors, targeted to the site of disease, has therefore become a great ambition in the field of Ad vector development. This review provides a synopsis of the structure/function relationships between Ad vectors and host systems and summarizes the many innovative approaches towards achieving Ad vector targeting.

Mesh:

Substances:

Year:  2007        PMID: 17584037      PMCID: PMC2244792          DOI: 10.2174/156652307780859062

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  187 in total

1.  Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.

Authors:  N Miyazawa; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Recombinant adenovirus vectors with knobless fibers for targeted gene transfer.

Authors:  V W van Beusechem; A L van Rijswijk; H H van Es; H J Haisma; H M Pinedo; W R Gerritsen
Journal:  Gene Ther       Date:  2000-11       Impact factor: 5.250

3.  High resolution solution structure of the 1.3S subunit of transcarboxylase from Propionibacterium shermanii.

Authors:  D V Reddy; B C Shenoy; P R Carey; F D Sönnichsen
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

4.  The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain.

Authors:  T Honda; H Saitoh; M Masuko; T Katagiri-Abe; K Tominaga; I Kozakai; K Kobayashi; T Kumanishi; Y G Watanabe; S Odani; R Kuwano
Journal:  Brain Res Mol Brain Res       Date:  2000-04-14

5.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon.

Authors:  J J Rux; R M Burnett
Journal:  Mol Ther       Date:  2000-01       Impact factor: 11.454

7.  Metabolic biotinylation of recombinant proteins in mammalian cells and in mice.

Authors:  M B Parrott; M A Barry
Journal:  Mol Ther       Date:  2000-01       Impact factor: 11.454

8.  Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein.

Authors:  I Kirby; E Davison; A J Beavil; C P Soh; T J Wickham; P W Roelvink; I Kovesdi; B J Sutton; G Santis
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol.

Authors:  M Y Nakano; K Boucke; M Suomalainen; R P Stidwill; U F Greber
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

10.  Blood clearance rates of adenovirus type 5 in mice.

Authors:  Ramon Alemany; Kaori Suzuki; David T Curiel
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

View more
  72 in total

1.  Self-assembly and optically triggered disassembly of hierarchical dendron-virus complexes.

Authors:  Mauri A Kostiainen; Oksana Kasyutich; Jeroen J L M Cornelissen; Roeland J M Nolte
Journal:  Nat Chem       Date:  2010-03-21       Impact factor: 24.427

2.  The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus.

Authors:  Chung-Huei K Wang; Leslie W Chan; Russell N Johnson; David S H Chu; Julie Shi; Joan G Schellinger; André Lieber; Suzie H Pun
Journal:  Biomaterials       Date:  2011-09-28       Impact factor: 12.479

3.  RhoA knockdown by cationic amphiphilic copolymer/siRhoA polyplexes enhances axonal regeneration in rat spinal cord injury model.

Authors:  So-Jung Gwak; Christian Macks; Da Un Jeong; Mark Kindy; Michael Lynn; Ken Webb; Jeoung Soo Lee
Journal:  Biomaterials       Date:  2017-01-03       Impact factor: 12.479

Review 4.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

5.  Three-dimensional structure of canine adenovirus serotype 2 capsid.

Authors:  Guy Schoehn; Majida El Bakkouri; Céline M S Fabry; Oliver Billet; Leandro F Estrozi; Long Le; David T Curiel; Andrey V Kajava; Rob W H Ruigrok; Eric J Kremer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

6.  The C-terminal domains of adenovirus serotype 5 protein IX assemble into an antiparallel structure on the facets of the capsid.

Authors:  Céline M S Fabry; Manuel Rosa-Calatrava; Christine Moriscot; Rob W H Ruigrok; Pierre Boulanger; Guy Schoehn
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

7.  Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus.

Authors:  S Kubo; M Takagi-Kimura; C R Logg; N Kasahara
Journal:  Cancer Gene Ther       Date:  2013-11-08       Impact factor: 5.987

8.  Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.

Authors:  Anniina Koski; Simona Bramante; Anja Kipar; Minna Oksanen; Juuso Juhila; Lotta Vassilev; Timo Joensuu; Anna Kanerva; Akseli Hemminki
Journal:  Mol Ther       Date:  2015-07-09       Impact factor: 11.454

9.  Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.

Authors:  Natalya Belousova; Galina Mikheeva; Juri Gelovani; Victor Krasnykh
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.